Skip to main content

Table 1 Provisional list of pathogens/presentations and MedDRA HLT term approved by consensus by the SAC

From: Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee

Opportunistic infections definitions/pathogens

MedDRA HLT

Definition of definite opportunistic infection in children with JIA

 1. Generally does not occur in the absence of immunosuppression and whose presence suggests a severe alteration in host immunity OR

 

 2. Can occur in patients without recognized forms of immunosuppression, but whose presence indicates a potential or likely alteration in host immunity

 

List of definite pathogens and/or presentations of specific pathogens

 

  Aspergillosis (invasive disease only)

Aspergillus infections

  Bartonellosis (disseminated disease only)

Bartonella infections

  BK virus disease including PVAN

BK virus infection

  Blastomycosis

Blastomyces infections

  Candidiasis (invasive disease or pharyngeal)

Candida infections

  Coccidioidomycosis

Coccidioides infections/Paracoccidioides infections

  Cryptococcosis

Cryptococcal infections

Cytomegalovirus disease with onset at age >  1 month: pneumonia (CMV in BAL), colitis, CNS disease (CMV in CSF), liver (biopsy), retina (confirmed by ophthalmologist), nephritis, myocarditis, pancreatitis

Cytomegaloviral infections

  HBV reactivation

Hepatitis viral infections

  Herpes simplex (invasive disease only)

Herpes viral infections

  Herpes zoster (any form)

Herpes viral infections

  Histoplasmosis

Histoplasma infections

  Legionellosis

Legionella infections

Listeria monocytogenes (invasive disease only)

Listeria infections

  Nocardiosis

Nocardia infections

  Non-tuberculous mycobacterium disease

Atypical mycobacterial infections

  Other invasive fungi: Mucormycosis (zygomycosis) (Rhizopus, Mucor and Lichtheimia), Scedosporium /Pseudallescheria boydii, Fusarium

Fungal infections NEC

Pneumocystis jirovecii

Pneumocystis infections

  Post-transplant lymphoproliferative disorder (EBV)

Epstein-Barr viral infections

  Progressive multifocal leucoencephalopathy

Polyomavirus infections

  Salmonellosis (invasive disease only)

Salmonella infections

  Strongyloides (hyperinfection syndrome and disseminated forms only)

Nematode infections

Toxoplasmosis of central nervous system, onset at age ≥ 1 month; Disseminated toxoplasmosis, visceral toxoplasmosis

Toxoplasma infections

  Tuberculosis

Tuberculous infections

Definition of probable opportunistic infection

 Published data is currently lacking, but expert opinion believes that risk is likely elevated in the setting of DMARD therapy. In case of the unusually severe course of infection due to a common pathogen with usually mild disease the pathogen might tentatively be considered opportunistic in a patient with impaired immune function. Below there is a non-exhaustive list of possible pathogens

 

List of probable pathogens and/or presentations of specific pathogens

  Campylobacteriosis (invasive disease only)

Campylobacter infections

Cryptosporidium species (chronic disease only)

Cryptosporidia infections

Enterovirus chronic encephalitis

Enteroviral infections NEC

Giardia, Isospora: chronic (> 1 month) diarrhea

Giardia infections/Isospora infections

  HCV progression

Hepatitis viral infections

Human Herpes Virus (HHV6–7): pneumonia, encephalitis

Herpes viral infections

Human Herpes Virus (HHV8): kaposi sarcoma

Herpes viral infections

Human metapneumovirus (hMPV): pneumonia, ARDS

Viral infections NEC

Human Papilloma Virus (HPV): extensive warts

Papilloma viral infections

Human respiratory syncytial virus (RSV): pneumonia with onset > 6 months of age

Respiratory syncytial viral infections

  Legionellosis

Legionella infections

  Leishmaniasis (Visceral only)

Leishmania infections

  Microsporidiosis

Protozoal infections NEC

Molluscum contagiosum: chronic, disseminated

Molluscum contagiosum

  Paracoccidioides infections

Paracoccidioides infections

Parvovirus B19: pure red cell aplasia

Parvoviral infections

Penicillium marneffei

Fungal infections NEC

Rota-Arena-Norovirus: chronic (> 1 month) diarrhea

Rotaviral infections/Arenaviral infections/Caliciviral infections

  Shigellosis (invasive disease only)

Shigella infections

Sporothrix schenckii

Sporothrix infections

  Trypanosoma cruzi infection (Chagas’ disease) (disseminated disease only)

Trypanosomal infections

Varicella: encephalitis (excluding cerebellitis), hepatitis, pneumonia

Herpes viral infections

  Vibriosis (invasive disease due to Vibrio vulnificus)

Vibrio infections

West Nile, Usutu: chronic encephalitis

Flaviviral infections

  1. In bold, those pathogens/presentations modified by the Safety Adjudication Committee (SAC) after consensus and literature review on the basis of Winthrop et al.’s paper [32]. PVAN polyomavirus-associated nephropathy, BAL bronchoalveolar lavage, CNS central nervous system, CSF cerebrospinal fluid, DMARD disease-modifying anti-rheumatic drug, CMV cytomegalovirus